Floatz logo

Avatrombopag

Liver Failure

Tongji HospitalSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Liver Failure cohort.

Asset / SponsorPhaseRating
Empagliflozin
Yale University
Phase 4BB
Pentoxifylline
Assistance Publique - Hôpitaux de Paris
Phase 3BB
Erythropoietin Human Recombinant
Institute of Liver and Biliary Sciences, India
Phase 3BB
SODIUM TETRADECYL SULFATE
Kaohsiung Veterans General Hospital.
Phase 3B
Everolimus
Azienda Ospedaliera di Padova
Phase 2B

View all 24 →

Same molecule, other indications

Avatrombopag is also rated in:

thrombocytopeniaDormant
BB
Indicative ·
70 / 100
View asset →
cirrhosis of liverDormant
BB
Indicative ·
65 / 100
View asset →
chemotherapy-induced toxicityDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →